RxDoctor Payments Data

Kenneth Moore, MD

Neurological Surgery · Indianapolis, INNPI 1013304054

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 42.8% of the total. Reporting peaked in 2023 at $3,681 and has fallen 77.4% since, to $831 in 2025.

$7,213in general payments, 2019–2025

Across 92 payments — averaging $78.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Medical Device Business Services, Inc.$2K
  • Stryker$1K
  • Imperative Care, Inc$483
  • Penumbra, Inc.$282
  • Integra Lifesciences Corporation$188
  • plus $234 from 4 others

What the payments were for

  • Travel & lodging$2,88940%
  • Food & beverage$4,30060%
  • Education$200%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,213 in reported general payments places this provider in the 65th percentile of 112 neurological surgery providers in Indiana.

See all neurological surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$124,828
Medicare patients
129
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin12$74

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →